T-PA AND THE PRINCIPLES OF DRUG APPROVAL

被引:12
作者
BORER, JS
机构
关键词
D O I
10.1056/NEJM198712243172609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1659 / 1661
页数:3
相关论文
共 5 条
[1]  
[Anonymous], 1986, Lancet, V1, P397
[2]   A RANDOMIZED TRIAL OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION WITH SUBSEQUENT RANDOMIZATION TO ELECTIVE CORONARY ANGIOPLASTY [J].
GUERCI, AD ;
GERSTENBLITH, G ;
BRINKER, JA ;
CHANDRA, NC ;
GOTTLIEB, SO ;
BAHR, RD ;
WEISS, JL ;
SHAPIRO, EP ;
FLAHERTY, JT ;
BUSH, DE ;
CHEW, PH ;
GOTTLIEB, SH ;
HALPERIN, HR ;
OUYANG, P ;
WALFORD, GD ;
BELL, WR ;
FATTERPAKER, AK ;
LLEWELLYN, M ;
TOPOL, EJ ;
HALEY, B ;
SIU, CO ;
BECKER, LC ;
WEISFELDT, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (26) :1613-1618
[3]   WESTERN WASHINGTON RANDOMIZED TRIAL OF INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
KENNEDY, JW ;
RITCHIE, JL ;
DAVIS, KB ;
FRITZ, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (24) :1477-1482
[4]  
SOBEL BE, 1984, HEART DISEASE TXB CA, V2, P1325
[5]  
1986, N ENGL J MED, V314, P165